UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000020652
Receipt No. R000023745
Scientific Title Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study.
Date of disclosure of the study information 2016/01/20
Last modified on 2019/05/16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study.
Acronym Association of FGF23 with urate metabolism in CKD patients.
Scientific Title Association of fibroblast growth factor 23 (FGF23) with urate metabolism in patients with chronic kidney disease (CKD): a cross-sectional study.
Scientific Title:Acronym Association of FGF23 with urate metabolism in CKD patients.
Region
Japan

Condition
Condition Chronic kidney disease
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To elucidate the association of FGF23 with urate metabolism in CKD patients.
Basic objectives2 Others
Basic objectives -Others This study is a cross-sectional one based on clinical data in each patient.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To explore factors associated with urate metabolism in CKD patients.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
999 years-old >
Gender Male and Female
Key inclusion criteria Patients who were admitted to our hospital for evaluation and education of CKD since June 2009 and gave written-informed consent.
Key exclusion criteria 1.Patients who did not give informed consent.

2.Patients who had no available data for FGF23 and urinary parameters.

3.Patients who experienced acute exacerbation of kidney disease.

Target sample size 99999

Research contact person
Name of lead principal investigator
1st name MASARU
Middle name
Last name NAKAYAMA
Organization National Hospital Organization
Kyushu Medical Center
Division name Nephrology
Zip code 810-8563
Address 1-8-1 Jigyohama, Chuo-Ku,Fukuoka 810-8563,Japan
TEL 092-852-0700
Email nakayama.masaru.kv@mail.hosp.go.jp

Public contact
Name of contact person
1st name MASARU
Middle name
Last name NAKAYAMA
Organization National Hospital Organization Kyushu Medical Center
Division name Nephrology
Zip code 810-8563
Address 1-8-1 Jigyohama, Chuo-Ku,Fukuoka 810-8563,Japan
TEL 092-852-0700
Homepage URL
Email nakayama.masaru.kv@mail.hosp.go.jp

Sponsor
Institute National Hospital Organization
Kyushu Medical Center
Institute
Department

Funding Source
Organization National Hospital Organization
Kyushu Medical Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Hospital Organization Kyushu Medical Center research ethics committee
Address 1-8-1 Jigyohama, Chuo-Ku,Fukuoka 810-8563,Japan
Tel 092-852-0700
Email nakayama.masaru.kv@mail.hosp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 01 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2009 Year 06 Month 01 Day
Date of IRB
2009 Year 05 Month 27 Day
Anticipated trial start date
2009 Year 06 Month 01 Day
Last follow-up date
2030 Year 05 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information prospective study
consecutive sampling

Management information
Registered date
2016 Year 01 Month 20 Day
Last modified on
2019 Year 05 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023745

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.